$BNET
BION ENVIRONMENTAL TECHNOLOGIES INC Stock $bnet

$bnet Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000107997323000655 Filed on May 10, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$0.00		$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$690.0K	$838.0K	$397.7K
YoY Change		110.69%	-64.31%
% of Gross Profit
Research & Development	$10.00K	$24.24K	$29.41K
YoY Change		-17.57%	-91.15%
% of Gross Profit
Depreciation & Amortization	$0.00	$461.00	$250.00
YoY Change		84.4%	21.36%
% of Gross Profit
Operating Expenses	$690.0K	$883.7K	$427.4K
YoY Change		106.76%	-70.46%
Operating Profit		-$883.7K	-$427.4K
YoY Change		106.76%	-70.46%
Interest Expense	$50.00K	$25.83K	-$50.02K
YoY Change		-151.64%	-136.27%
% of Operating Profit
Other Income/Expense, Net		$25.83K	$852.5K
YoY Change		-96.97%	-926.75%
Pretax Income	-$680.0K	-$857.9K	$425.1K
YoY Change		-301.83%	-127.43%
Income Tax
% Of Pretax Income
Net Earnings	-$680.0K	-$857.9K	$425.6K
YoY Change		-301.57%	-127.46%
Net Earnings / Revenue
Basic Earnings Per Share		-$0.02
Diluted Earnings Per Share	-$0.01	-$0.02	$9.891K
COMMON SHARES
Basic Shares Outstanding	47.34M shares	43.63M shares
Diluted Shares Outstanding		45.46M shares	43.03M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$630.0K	$1.613M	$3.602M
YoY Change		-55.22%	115.6%
Cash & Equivalents	$626.0K	$1.613M	$3.602M
Short-Term Investments
Other Short-Term Assets	$30.00K	$119.1K	$51.27K
YoY Change		132.3%	626.2%
Inventory
Prepaid Expenses	$16.79K	$113.1K
Receivables
Other Receivables
Total Short-Term Assets	$648.7K	$1.732M	$4.556M
YoY Change	-80.45%	-61.98%	171.54%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.851M	$5.788M	$1.992M
YoY Change	136.6%	190.53%	266252.94%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$6.945M	$5.895M	$1.992M
YoY Change	128.35%	195.9%	266252.94%
TOTAL ASSETS
Total Short-Term Assets	$648.7K	$1.732M	$4.556M
Total Long-Term Assets	$6.945M	$5.895M	$1.992M
Total Assets	$7.594M	$7.627M	$6.548M
YoY Change	19.39%	16.48%	290.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$680.0K	$800.9K	$1.218M
YoY Change		-34.24%	121.87%
Accrued Expenses	$80.00K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due			$0.00
YoY Change			-100.0%
Total Short-Term Liabilities	$1.617M	$1.585M	$1.744M
YoY Change	-17.31%	-9.08%	-84.7%
LONG-TERM LIABILITIES
Long-Term Debt	$1.720M	$1.736M	$5.123M
YoY Change		-66.12%	7.9%
Other Long-Term Liabilities	$30.00K	$120.0K	$125.7K
YoY Change		-4.57%
Total Long-Term Liabilities	$1.750M	$1.855M	$5.249M
YoY Change		-64.65%	10.55%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.617M	$1.585M	$1.744M
Total Long-Term Liabilities	$1.750M	$1.855M	$5.249M
Total Liabilities	$3.362M	$3.441M	$7.030M
YoY Change	-53.66%	-51.06%	-56.45%
SHAREHOLDERS EQUITY
Retained Earnings	-$127.2M	-$126.6M
YoY Change	2.57%
Common Stock	$0.00	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$4.194M	$4.149M	-$481.8K
YoY Change
Total Liabilities & Shareholders Equity	$7.594M	$7.627M	$6.548M
YoY Change	19.39%	16.48%	290.11%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$680.0K	-$857.9K	$425.6K
YoY Change		-301.57%	-127.46%
Depreciation, Depletion And Amortization	$0.00	$461.00	$250.00
YoY Change		84.4%	21.36%
Cash From Operating Activities	-$450.0K	-$559.3K	-$270.9K
YoY Change		106.5%	-23.75%
INVESTING ACTIVITIES
Capital Expenditures	$1.160M	$1.664M	-$1.075M
YoY Change		-254.76%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$1.160M	-$1.664M	-$1.075M
YoY Change		54.76%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	610.0K	2.735M	0.000
YoY Change			-100.0%
NET CHANGE
Cash From Operating Activities	-450.0K	-559.3K	-270.9K
Cash From Investing Activities	-1.160M	-1.664M	-1.075M
Cash From Financing Activities	610.0K	2.735M	0.000
Net Change In Cash	-1.000M	511.5K	-1.346M
YoY Change		-138.0%	-202.8%
FREE CASH FLOW
Cash From Operating Activities	-$450.0K	-$559.3K	-$270.9K
Capital Expenditures	$1.160M	$1.664M	-$1.075M
Free Cash Flow	-$1.610M	-$2.223M	$804.5K
YoY Change		-376.39%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax		usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax		usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax		usd
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables		usd
	bnet	Proceeds From Sale Of Units ProceedsFromSaleOfUnits		usd
	us-gaap	Payments For Repurchase Of Warrants PaymentsForRepurchaseOfWarrants		usd
	bnet	Commissions On Sale Of Units CommissionsOnSaleOfUnits		usd
	bnet	Redemption Of Preferred Series B Shares And Interest RedemptionOfPreferredSeriesBSharesAndInterest		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	bnet	Conversion Of Debt And Liabilities Into Notes Payable ConversionOfDebtAndLiabilitiesIntoNotesPayable		usd
	bnet	Capitalized Interest In Property And Equipment CapitalizedInterestInPropertyAndEquipment		usd
	bnet	Shares Issued For Warrant Exercise Commissions SharesIssuedForWarrantExerciseCommissions		usd
CY2022Q1	bnet	Weighted Average Shares Issued During Period WeightedAverageSharesIssuedDuringPeriod		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	dei	Entity Central Index Key EntityCentralIndexKey	0000875729
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
CY2023Q1	us-gaap	Common Stock Value CommonStockValue		usd
CY2022Q2	us-gaap	Common Stock Value CommonStockValue		usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax		usd
CY2023Q1	bnet	Gain On Sale Of Domains GainOnSaleOfDomains		usd
	bnet	Gain On Sale Of Domains GainOnSaleOfDomains		usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
	bnet	Gain On Legal Dissolutions Of Subsidiary GainOnLegalDissolutionsOfSubsidiary		usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-19333
	dei	Entity Registrant Name EntityRegistrantName	Bion Environmental Technologies, Inc
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	CO
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	84-1176672
	dei	Entity Address Address Line1 EntityAddressAddressLine1	9 East Park Court
	dei	Entity Address City Or Town EntityAddressCityOrTown	Old Bethpage
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	11804
	dei	City Area Code CityAreaCode	516
	dei	Local Phone Number LocalPhoneNumber	586-5643
	dei	Security12b Title Security12bTitle	Common Stock
	dei	Trading Symbol TradingSymbol	BNET
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	47342061	shares
CY2023Q1	us-gaap	Cash Cash	1612977	usd
CY2022Q2	us-gaap	Cash Cash	3160442	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	113101	usd
CY2022Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	157550	usd
CY2023Q1	us-gaap	Deposits Assets Current DepositsAssetsCurrent	6000	usd
CY2022Q2	us-gaap	Deposits Assets Current DepositsAssetsCurrent	1000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	1732078	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	3318992	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	107162	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	145787	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5788203	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2895558	usd
CY2023Q1	us-gaap	Assets Assets	7627443	usd
CY2022Q2	us-gaap	Assets Assets	6360337	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	800901	usd
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1360644	usd
CY2023Q1	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	784255	usd
CY2022Q2	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	594798	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	1585156	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	1955442	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	119951	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	128864	usd
CY2023Q1	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	1735507	usd
CY2022Q2	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	5170610	usd
CY2023Q1	us-gaap	Liabilities Liabilities	3440614	usd
CY2022Q2	us-gaap	Liabilities Liabilities	7254916	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	48044790	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43758820	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	47340480	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	43054511	shares
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	131208759	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	123620046	usd
CY2023Q1	us-gaap	Common Stock Share Subscribed But Unissued Subscriptions Receivable CommonStockShareSubscribedButUnissuedSubscriptionsReceivable	504650	usd
CY2022Q2	us-gaap	Common Stock Share Subscribed But Unissued Subscriptions Receivable CommonStockShareSubscribedButUnissuedSubscriptionsReceivable	504650	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-126554853	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-124047548	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	4149256	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-932152	usd
CY2023Q1	us-gaap	Minority Interest MinorityInterest	37573	usd
CY2022Q2	us-gaap	Minority Interest MinorityInterest	37573	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4186829	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-894579	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7627443	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6360337	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	859011	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	397743	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2356047	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1506839	usd
CY2023Q1	us-gaap	Depreciation Depreciation	461	usd
CY2022Q1	us-gaap	Depreciation Depreciation	252	usd
	us-gaap	Depreciation Depreciation	1185	usd
	us-gaap	Depreciation Depreciation	832	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	24242	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	29411	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	67833	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	145624	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	883714	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	427406	usd
	us-gaap	Operating Expenses OperatingExpenses	2425065	usd
	us-gaap	Operating Expenses OperatingExpenses	1653295	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-883714	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-427406	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2425065	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1653295	usd
CY2023Q1	us-gaap	Interest Income Operating InterestIncomeOperating	1342	usd
CY2022Q1	us-gaap	Interest Income Operating InterestIncomeOperating	1338	usd
	us-gaap	Interest Income Operating InterestIncomeOperating	4652	usd
	us-gaap	Interest Income Operating InterestIncomeOperating	4101	usd
CY2023Q1	bnet	Interests Expense InterestsExpense	-24488	usd
CY2022Q1	bnet	Interests Expense InterestsExpense	51361	usd
	bnet	Interests Expense InterestsExpense	86892	usd
	bnet	Interests Expense InterestsExpense	281906	usd
CY2022Q1	bnet	Gain On Sale Of Domains GainOnSaleOfDomains	-902490	usd
	bnet	Gain On Sale Of Domains GainOnSaleOfDomains	-902490	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	10234501	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	25830	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	852467	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-82240	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	10859186	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-857884	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	425061	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2507305	usd
	us-gaap	Net Income Loss NetIncomeLoss	9205891	usd
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-549	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1544	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-857884	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	425610	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2507305	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	9207435	usd
CY2023Q1	bnet	Net Income Loss Applicable To Bions Common Stockholders Per Basic And Diluted Common Share NetIncomeLossApplicableToBionsCommonStockholdersPerBasicAndDilutedCommonShare	-0.02
CY2022Q1	bnet	Net Income Loss Applicable To Bions Common Stockholders Per Basic And Diluted Common Share NetIncomeLossApplicableToBionsCommonStockholdersPerBasicAndDilutedCommonShare	0.01
	bnet	Net Income Loss Applicable To Bions Common Stockholders Per Basic And Diluted Common Share NetIncomeLossApplicableToBionsCommonStockholdersPerBasicAndDilutedCommonShare	-0.06
	bnet	Net Income Loss Applicable To Bions Common Stockholders Per Basic And Diluted Common Share NetIncomeLossApplicableToBionsCommonStockholdersPerBasicAndDilutedCommonShare	0.22
CY2023Q1	us-gaap	Weighted Average Number Of Limited Partnership And General Partnership Unit Outstanding Basic And Diluted WeightedAverageNumberOfLimitedPartnershipAndGeneralPartnershipUnitOutstandingBasicAndDiluted	45456417	shares
CY2022Q1	us-gaap	Weighted Average Number Of Limited Partnership And General Partnership Unit Outstanding Basic And Diluted WeightedAverageNumberOfLimitedPartnershipAndGeneralPartnershipUnitOutstandingBasicAndDiluted	43029511	shares
	us-gaap	Weighted Average Number Of Limited Partnership And General Partnership Unit Outstanding Basic And Diluted WeightedAverageNumberOfLimitedPartnershipAndGeneralPartnershipUnitOutstandingBasicAndDiluted	44165309	shares
	us-gaap	Weighted Average Number Of Limited Partnership And General Partnership Unit Outstanding Basic And Diluted WeightedAverageNumberOfLimitedPartnershipAndGeneralPartnershipUnitOutstandingBasicAndDiluted	41602390	shares
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-873900	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4650	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	425061	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-444189	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1536874	usd
CY2023Q1	bnet	Sale Of Units Value SaleOfUnitsValue	2720000	usd
CY2023Q1	bnet	Warrants Exercised For Common Shares WarrantsExercisedForCommonShares	63000	usd
CY2023Q1	bnet	Issuance Of Warrants For Services IssuanceOfWarrantsForServices	9844	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	99889	usd
CY2023Q1	bnet	Vesting Of Options For Employees And Services VestingOfOptionsForEmployeesAndServices	220510	usd
CY2023Q1	bnet	Stock Issued During Period Value Commissions On Sale Of Units StockIssuedDuringPeriodValueCommissionsOnSaleOfUnits	-48000	usd
CY2023Q1	bnet	Debt Modification DebtModification	3516345	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-857884	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4186829	usd
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-11406339	usd
	bnet	Warrants Exercised For Common Shares WarrantsExercisedForCommonShares	1736662	usd
	bnet	Commissions On Warrant Exercises CommissionsOnWarrantExercises	-18601	usd
	bnet	Issuance Of Warrants For Services IssuanceOfWarrantsForServices	7500	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	17711	usd
	bnet	Vesting Of Options For Employees And Services VestingOfOptionsForEmployeesAndServices	4650	usd
	bnet	Adjustment To Additional Paid In Capital Modification Of Warrants AdjustmentToAdditionalPaidInCapitalModificationOfWarrants	8337	usd
	us-gaap	Profit Loss ProfitLoss	9205891	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-444189	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-894579	usd
	bnet	Sale Of Units Value SaleOfUnitsValue	3266230	usd
	bnet	Warrants Exercised For Common Shares WarrantsExercisedForCommonShares	119125	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	80000	usd
	bnet	Issuance Of Warrants For Services IssuanceOfWarrantsForServices	57094	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	149889	usd
	bnet	Vesting Of Options For Employees And Services VestingOfOptionsForEmployeesAndServices	220510	usd
	bnet	Stock Issued During Period Value Commissions On Sale Of Units StockIssuedDuringPeriodValueCommissionsOnSaleOfUnits	-48000	usd
	bnet	Modification Of Warrants Noncash Comp ModificationOfWarrantsNoncashComp	159433	usd
	bnet	Modification Of Warrants Interest ModificationOfWarrantsInterest	68088	usd
	bnet	Debt Modification DebtModification	3516345	usd
	us-gaap	Profit Loss ProfitLoss	-2507305	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4186829	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2507305	usd
	us-gaap	Net Income Loss NetIncomeLoss	9205891	usd
	bnet	Gain On Legal Dissolutions Of Subsidiary GainOnLegalDissolutionsOfSubsidiary	10234501	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1185	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	832	usd
	us-gaap	Other Noncash Expense OtherNoncashExpense	86891	usd
	us-gaap	Other Noncash Expense OtherNoncashExpense	299770	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	220510	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	17774	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	80000	usd
	bnet	Modification Of Warrants ModificationOfWarrants	154932	usd
	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	57094	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-44449	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-118778	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	5000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	45000	usd
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	902490	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-908644	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	223822	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	29712	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-33073	usd
	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	265000	usd
	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	224367	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2481176	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1123830	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2403644	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1167463	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2403644	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1167463	usd
	bnet	Proceeds From Sale Of Units ProceedsFromSaleOfUnits	3266230	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	119125	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1736662	usd
	us-gaap	Payments For Repurchase Of Warrants PaymentsForRepurchaseOfWarrants	18601	usd
	bnet	Commissions On Sale Of Units CommissionsOnSaleOfUnits	48000	usd
	bnet	Redemption Of Preferred Series B Shares And Interest RedemptionOfPreferredSeriesBSharesAndInterest	-41000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3337355	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1677061	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1547465	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-614232	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3160442	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4216321	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1612977	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3602089	usd
	bnet	Conversion Of Debt And Liabilities Into Common Units ConversionOfDebtAndLiabilitiesIntoCommonUnits	149888	usd
	bnet	Conversion Of Debt And Liabilities Into Common Units ConversionOfDebtAndLiabilitiesIntoCommonUnits	17711	usd
	bnet	Conversion Of Debt And Liabilities Into Notes Payable ConversionOfDebtAndLiabilitiesIntoNotesPayable	23943	usd
	bnet	Conversion Of Deferred Compensation To Notes Payable ConversionOfDeferredCompensationToNotesPayable	90000	usd
	bnet	Conversion Of Deferred Compensation To Notes Payable ConversionOfDeferredCompensationToNotesPayable	190000	usd
	bnet	Capitalized Interest In Property And Equipment CapitalizedInterestInPropertyAndEquipment	117342	usd
	bnet	Shares Issued For Warrant Exercise Commissions SharesIssuedForWarrantExerciseCommissions	50145	usd
	bnet	Purchase Of Property And Equipment For Accounts Payable PurchaseOfPropertyAndEquipmentForAccountsPayable	372844	usd
	bnet	Purchase Of Property And Equipment For Accounts Payable PurchaseOfPropertyAndEquipmentForAccountsPayable	666375	usd
	bnet	Cattle Per Head CattlePerHead	300	decimal
	bnet	Techwastage Techwastage	1500	decimal
	bnet	Percentage Of Sustainable PercentageOfSustainable	0.295	pure
	bnet	Description Of Kreider2 Poultry Project DescriptionOfKreider2PoultryProject	Bion has done extensive pre-development work related to a waste treatment/renewable energy production facility to treat the waste from KF’s approximately 6+ million chickens (planned to expand to approximately 9-10 million) (and potentially other poultry operations and/or other waste streams) (‘Kreider Renewable Energy Facility’ or ‘Kreider 2 Project’). On May 5, 2016, the Company executed a stand-alone joint venture agreement (“JVA”) with Kreider Farms covering all matters related to development and operation of Kreider 2 system to treat the waste streams from Kreider’s poultry facilities in Bion PA2 LLC (“PA2”). Now that development of the Company’s Gen3Tech is being deployed, the Company has commenced discussions with KF regarding updating and amending the JV agreement and anticipates executing an amended joint venture agreement during 2023. During May 2011 the PADEP certified a smaller version of the Kreider 2 Project (utilizing our 2nd generation technology) under the old EPA’s Chesapeake Bay model. The Company anticipates that if and when new designs are finalized utilizing our Gen3Tech, a larger Kreider 2 Project will be re-certified for a far larger number of credits (management’s current estimates are between 2-4 million (or more) nutrient reduction credits for treatment of the waste stream from Kreider’s poultry pursuant to the amended EPA Chesapeake Bay model and agreements between the EPA and PA).
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	3451000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	8291000	usd
CY2022	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	10235000	usd
CY2022	bnet	Gain On Sale Of Domain Amount GainOnSaleOfDomainAmount	902000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	2507305	usd
CY2023Q1	bnet	Working Capital WorkingCapital	147000	usd
CY2023Q1	bnet	Reduction Of Debt ReductionOfDebt	3516000	usd
CY2022	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	1737000	usd
CY2021	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	5209000	usd
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	3385000	usd
	us-gaap	Payments For Commissions PaymentsForCommissions	48000	usd
CY2018	bnet	Deferred Compensation Liability Amount Cancelled DeferredCompensationLiabilityAmountCancelled	2404000	usd
CY2023Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2022Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2023Q1	bnet	Shares Held By Subsidiaries SharesHeldBySubsidiaries	-704309	shares
CY2022Q1	bnet	Shares Held By Subsidiaries SharesHeldBySubsidiaries	-704309	shares
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_846_eus-gaap--ConcentrationRiskCreditRisk_zlNiLHrytcZ9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86A_zf5RbMvY45d2"><span id="xdx_862_z3RIdWiJl8Ug">Concentrations of credit risk</span>:</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company's financial instruments that are exposed to concentrations of credit risk consist of cash. The Company's cash is in demand deposit accounts placed with federally insured financial institutions and selected brokerage accounts. Such deposit accounts at times may exceed federally insured limits. The Company has not experienced any losses on such accounts.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
	bnet	Shares Held By Subsidiaries SharesHeldBySubsidiaries	-704309	shares
	bnet	Shares Held By Subsidiaries SharesHeldBySubsidiaries	-704309	shares
CY2023Q1	bnet	Shares Outstanding Beginning Of Period SharesOutstandingBeginningOfPeriod	43825575	shares
CY2023Q1	bnet	Shares Issued Beginning Of Period SharesIssuedBeginningOfPeriod	44529884	shares
CY2022Q1	bnet	Shares Issued Beginning Of Period SharesIssuedBeginningOfPeriod	43733850	shares
	bnet	Shares Issued Beginning Of Period SharesIssuedBeginningOfPeriod	43758820	shares
	bnet	Shares Issued Beginning Of Period SharesIssuedBeginningOfPeriod	41315986	shares
CY2022Q1	bnet	Shares Outstanding Beginning Of Period SharesOutstandingBeginningOfPeriod	43029511	shares
	bnet	Shares Outstanding Beginning Of Period SharesOutstandingBeginningOfPeriod	43054511	shares
	bnet	Shares Outstanding Beginning Of Period SharesOutstandingBeginningOfPeriod	40611677	shares
CY2023Q1	bnet	Weighted Average Shares Issued During Period WeightedAverageSharesIssuedDuringPeriod	1630842	shares
	bnet	Weighted Average Shares Issued During Period WeightedAverageSharesIssuedDuringPeriod	1110798	shares
	bnet	Weighted Average Shares Issued During Period WeightedAverageSharesIssuedDuringPeriod	990713	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	45456417	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43029511	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	44165309	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40904342	shares
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_842_eus-gaap--UseOfEstimates_zgFXVN5MAn32" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_865_zT07NLJmP0U2"><span><span><span id="xdx_869_zxysJx5NwgPf"><span id="xdx_869_zmERQ4oR6bMg">Use of estimates</span>:</span></span></span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In preparing the Company’s condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p>
CY2023Q1	bnet	Computers And Office Equipment ComputersAndOfficeEquipment	15156	usd
CY2022Q2	bnet	Computers And Office Equipment ComputersAndOfficeEquipment	13598	usd
CY2023Q1	us-gaap	Construction In Progress Gross ConstructionInProgressGross	5784494	usd
CY2022Q2	us-gaap	Construction In Progress Gross ConstructionInProgressGross	2892222	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5799650	usd
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2905820	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11447	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	10262	usd
CY2023Q1	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	5788203	usd
CY2022Q2	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	2895558	usd
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	149342	usd
	bnet	Non Cash Compensation NonCashCompensation	135648	usd
CY2023Q1	us-gaap	Depreciation Depreciation	461	usd
CY2022Q1	us-gaap	Depreciation Depreciation	252	usd
	us-gaap	Depreciation Depreciation	1185	usd
	us-gaap	Depreciation Depreciation	832	usd
CY2023Q1	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	784255	usd
CY2022Q1	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	525699	usd
CY2023Q1	bnet	Interest Rate On Deferred Compensation InterestRateOnDeferredCompensation	0.04	pure
	bnet	Deferred Compensation Consecutive Trading Days DeferredCompensationConsecutiveTradingDays	P10D
CY2023Q1	us-gaap	Deferred Compensation Liability Current And Noncurrent DeferredCompensationLiabilityCurrentAndNoncurrent	110000	usd
CY2022Q1	us-gaap	Deferred Compensation Liability Current And Noncurrent DeferredCompensationLiabilityCurrentAndNoncurrent	0	usd
CY2021Q3	us-gaap	Assets Assets	297	usd
CY2021Q3	us-gaap	Liabilities Liabilities	10154334	usd
CY2021Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	9939148	usd
CY2021Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	214235	usd
CY2021Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	950	usd
CY2021Q4	us-gaap	Liabilities Liabilities	10234501	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	10009802	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	212263	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	12436	usd
	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary	10234501	usd
CY2021Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	9868495	usd
CY2023Q1	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.50
CY2023Q1	us-gaap	Costs Incurred Development Costs CostsIncurredDevelopmentCosts	51238	usd
CY2022Q1	us-gaap	Costs Incurred Development Costs CostsIncurredDevelopmentCosts	0	usd
	us-gaap	Costs Incurred Development Costs CostsIncurredDevelopmentCosts	117342	usd
	us-gaap	Costs Incurred Development Costs CostsIncurredDevelopmentCosts	0	usd
CY2023Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	3470000	usd
CY2023Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	3470000	usd
CY2023Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	3470000	usd
CY2023Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	3470000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	3521000	usd
CY2023Q1	bnet	Reduction Of Additional Paid In Capital ReductionOfAdditionalPaidInCapital	5620	usd
	bnet	Redemption Of Convertible Preferred Stock RedemptionOfConvertiblePreferredStock	41000	usd
	bnet	Shares Held By Subsidiaries SharesHeldBySubsidiaries	-704309	shares
CY2023Q1	us-gaap	Payments For Commissions PaymentsForCommissions	48000	usd
CY2023Q1	bnet	Class Of Warrant Or Right Exercised During Period ClassOfWarrantOrRightExercisedDuringPeriod	84000	shares
CY2023Q1	bnet	Common Stock Shares Issued Upon Exercise Of Warrants CommonStockSharesIssuedUponExerciseOfWarrants	84000	shares
CY2023Q1	bnet	Warrants Exercised For Common Stock WarrantsExercisedForCommonStock	63000	usd
CY2023Q1	bnet	Sale Of Unit Price Per Unit SaleOfUnitPricePerUnit	1.00
CY2023Q1	us-gaap	Share Price SharePrice	0.75
	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	346230	shares
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	346230	usd
	us-gaap	Payments For Commissions PaymentsForCommissions	48000	usd
	bnet	Class Of Warrant Or Right Exercised During Period ClassOfWarrantOrRightExercisedDuringPeriod	158834	shares
	bnet	Common Stock Shares Issued Upon Exercise Of Warrants CommonStockSharesIssuedUponExerciseOfWarrants	158834	shares
	bnet	Warrants Exercised For Common Stock WarrantsExercisedForCommonStock	119125	usd
CY2023Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	21900000	shares
	bnet	Class Of Warrant Or Right Exercised During Period ClassOfWarrantOrRightExercisedDuringPeriod	158834	shares
	bnet	Common Stock Shares Issued Upon Exercise Of Warrants CommonStockSharesIssuedUponExerciseOfWarrants	158834	shares
	bnet	Warrants Exercised For Common Stock WarrantsExercisedForCommonStock	119125	usd
CY2022Q2	bnet	Sharebased Compensation Granted SharebasedCompensationGranted	720000	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11201600	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.80
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y8M12D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	4429263	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	305000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11506600	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.82
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y7D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	10238395	usd
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	220510	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	220510	usd
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	4650	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	4650	usd
CY2022Q2	bnet	Compensation Increased CompensationIncreased	25000	usd
CY2022Q1	bnet	Exercise Bonus ExerciseBonus	0.75	pure
	bnet	Warrants Held By Trust Owned WarrantsHeldByTrustOwned	3000000	usd
CY2023Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	18438339	usd
CY2022Q1	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	2665500	usd
CY2022Q1	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.25	pure
CY2022Q1	us-gaap	Debt Instrument Periodic Payment DebtInstrumentPeriodicPayment	666375	usd
CY2022Q1	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.25	pure
CY2022Q2	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.25	pure
CY2023Q1	us-gaap	Debt Instrument Periodic Payment DebtInstrumentPeriodicPayment	533100	usd
CY2023Q1	bnet	Aggregate Payment AggregatePayment	2532225	usd
CY2022Q2	bnet	Purchase Order PurchaseOrder	133275	usd
CY2022Q2	bnet	Purchase Order Billed PurchaseOrderBilled	86275	usd
CY2022Q2	bnet	Purchase Order Invoiced PurchaseOrderInvoiced	50000	usd
	us-gaap	Interest Costs Incurred Capitalized InterestCostsIncurredCapitalized	5164256	usd
CY2022Q1	bnet	Sale Of Domain Description SaleOfDomainDescription	the Company entered into an agreement to sell domain name <biontech.com> and other related assets to BioNTech SE (“BNTX”) for the sum of $950,000 (before expenses related to the transaction) which sale was closed/completed on April 2, 2022 with a one-time gain of $902,490.
CY2021Q4	us-gaap	Long Term Construction Loan Current LongTermConstructionLoanCurrent	10010000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	2255802	usd
CY2021Q3	us-gaap	Assets Assets	297	usd
CY2021Q3	us-gaap	Liabilities Liabilities	10154334	usd
CY2021Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	9939148	usd
CY2021Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	214235	usd
CY2021Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	950	usd
CY2021Q4	us-gaap	Assets Assets	0	usd
CY2021Q4	us-gaap	Liabilities Liabilities	10234501	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	10009802	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	212263	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	12436	usd
	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax	10234501	usd
CY2021Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	9868495	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	18750	usd
CY2023Q1	us-gaap	Operating Leases Future Minimum Payments Receivable In Two Years OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears	56250	usd
CY2023Q1	us-gaap	Operating Leases Future Minimum Payments Receivable In Three Years OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears	75000	usd
CY2023Q1	bnet	Undiscounted Cash Flow UndiscountedCashFlow	131250	usd
CY2023Q1	bnet	Less Imputed Interest LessImputedInterest	-11299	usd
CY2023Q1	us-gaap	Capital Leases Contingent Rental Payments Due CapitalLeasesContingentRentalPaymentsDue	119951	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y9M29D
CY2023Q1	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.10	pure
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	18750	usd

Files In Submission

Name	View Source	Status
0001079973-23-000655-index-headers.html	Edgar Link	pending
0001079973-23-000655-index.html	Edgar Link	pending
0001079973-23-000655.txt	Edgar Link	pending
0001079973-23-000655-xbrl.zip	Edgar Link	pending
bion_10q-q3.htm	Edgar Link	pending
bnet-20230331.xsd	Edgar Link	pending
bnet-20230331_def.xml	Edgar Link	unprocessable
bnet-20230331_cal.xml	Edgar Link	unprocessable
bnet-20230331_lab.xml	Edgar Link	unprocessable
bion_10q-q3_htm.xml	Edgar Link	completed
ex31x1.htm	Edgar Link	pending
ex31x2.htm	Edgar Link	pending
ex32x1.htm	Edgar Link	pending
ex32x2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
bnet-20230331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BNET
BION ENVIRONMENTAL TECHNOLOGIES INC Stock $bnet

2023 Q2 Form 10-Q Financial Statement

#000107997323000655 Filed on May 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BNET BION ENVIRONMENTAL TECHNOLOGIES INC Stock $bnet

2023 Q2 Form 10-Q Financial Statement

#000107997323000655 Filed on May 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BNET
BION ENVIRONMENTAL TECHNOLOGIES INC Stock $bnet